Want to see PETS full AI Analyst Report?
PETS Stock Chart & Stats
$1.76
-$0.06(-2.93%)
At close: 4:00 PM EDT
$1.76
-$0.06(-2.93%)
Day’s Range― - ―
52-Week Range$1.57 - $4.10
Previous CloseN/A
Volume103.65K
Average Volume (3M)105.65K
Market Cap
$34.69M
Enterprise Value$28.97
Total Cash (Recent Filing)$13.08M
Total Debt (Recent Filing)$414.00K
Price to Earnings (P/E)―
Beta1.51
Next Earnings
Nov 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.4%
Share Statistics
EPS (TTM)-1.38
Shares Outstanding21,678,913
10 Day Avg. Volume107,362
30 Day Avg. Volume105,653
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.65
Price to Sales (P/S)0.27
P/FCF Ratio-1.45
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$2.15Price Target Upside22.16% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)0.07
Revenue Forecast (FY)$180.32M
Bulls Say, Bears Say
Bulls Say
Financial StabilityThe business is well-capitalized to make it through the turnaround, with $50M of cash and no debt.
Management StrategyThe new strategy is focused on consolidating brands, improving the supply chain, focusing on customer retention, driving site traffic, improving the marketing approach, and upgrading the technology platforms.
Bears Say
Customer RetentionThe company is likely losing customers to competitors with the absence of promotions.
Financial PerformanceThe business has not shown growth on an organic basis in over 12 quarters, which is largely driven by competitive pressures.
Revenue DeclineQ2 revenue declined 16% to $59.6M, which was below the $66.0M estimate, indicating customers reduced spending or sought promotions from competitors.
Petmed Express News
PETS FAQ
What was Petmed Express’s price range in the past 12 months?
Petmed Express lowest stock price was $1.57 and its highest was $4.10 in the past 12 months.
What is Petmed Express’s market cap?
Petmed Express’s market cap is $34.69M.
When is Petmed Express’s upcoming earnings report date?
Petmed Express’s upcoming earnings report date is Nov 10, 2026 which is in 48 days.
How were Petmed Express’s earnings last quarter?
Petmed Express released its earnings results on Aug 13, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of $0.12 by -$0.4.
Is Petmed Express overvalued?
According to Wall Street analysts Petmed Express’s price is currently Undervalued.
Does Petmed Express pay dividends?
Petmed Express pays a Quarterly dividend of $0.3 which represents an annual dividend yield of 9.4%. See more information on Petmed Express dividends here
What is Petmed Express’s EPS estimate?
Petmed Express’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Petmed Express have?
Petmed Express has 21,678,913 shares outstanding.
What happened to Petmed Express’s price movement after its last earnings report?
Petmed Express reported an EPS of -$0.28 in its last earnings report, missing expectations of $0.12. Following the earnings report the stock price went down -10.099%.
Which hedge fund is a major shareholder of Petmed Express?
Currently, no hedge funds are holding shares in PETS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Petmed Express Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$2.15 (22.16% Upside)
$2.15 (22.16% Upside)
Blogger Sentiment
Neutral
PETS Sentiment 100%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 514.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.39%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-41.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Petmed Express
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
PETS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a cautiously optimistic tone: management reported substantial progress on cost reductions, major technology and operational upgrades (SAP rollout, call center, fraud prevention), improved customer acquisition efficiency (70k new customers; CAC down 15%), higher recurring revenue mix (61.5% of sales), strategic white-label partnership with Rural King, and a sale-leaseback to unlock $37M of real estate value. However, notable challenges remain, including a 19.9% year-over-year revenue decline driven by weaker prescription sales, lower gross profit, an increased adjusted EBITDA loss, and an outstanding unsolicited acquisition proposal. On balance, the operational and financial improvements and strategic initiatives meaningfully outweigh the current headwinds, but execution risk on pending transactions and sustained revenue recovery remain important considerations.View all PETS earnings summariesPETS Stock 12 Month Forecast
Average Price Target
$2.15
▲(22.16% Upside)
Technical Analysis
Tractor Supply
―
Chewy
―
Boqii Holding
―
BARK Inc Class A
―
Petco Health and Wellness Company
―
Ownership Overview
15.60% Insiders
11.88% Mutual Funds
2.41% Other Institutional Investors
65.59% Public Companies and
Individual Investors